HomeAI · summaries
Storia in 3 fonti
Veracyte genomic test identifies breast cancer patients who can skip chemo
Veracyte's genomic test identifies high-risk breast cancer patients who can safely skip chemotherapy, enhancing personalized treatment options.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
theguardian.com
‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy
Karen Bonham was part of successful trial for genomic test that determines which women with breast cancer can safely avoid chemotherapy
- ·
Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy
Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes
